fashion -WSS

fashion

author：fashion 2025-10-02 20:48:54 - browse：7

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Medicare Advantage 2025 payments will dip, Biden administration says

hotspot

WSS

Trial using CRISPR to edit HIV out of cells disappoints

Florida Supreme Court upholds state's abortion ban

Medicare must police algorithms in Medicare Advantage, Dems say

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Insurer loopholes limit power of law against surprise medical bills

Gene therapy’s promise and the high cost of hope

hotspot

fashion

hotspot

How one medical school became remarkably diverse

Scientists uncover potential path to treating deadly childhood tumor

Alkermes shareholders re

Pancreatic cancer is often deadly, but new discoveries are raising hope

Psychedelics group wrestles with new pharma identity

The health care issue Democrats can’t solve: hospital reform

State Dept. review finds Biden bears some blame for Afghanistan failures

Key Senate panel to consider PBM, drug pricing reform package

Duchenne breakthrough therapy leaves behind pioneering families

UnitedHealth, in a surprise, takes aim at Steward’s physician group

focus

U.K. decision on ALS drug has neurologists, advocates up in arms

Hundreds died while taking an arthritis drug, but nobody alerted patients

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Key Senate panel to consider PBM, drug pricing reform package

Pancreatic cancer is often deadly, but new discoveries are raising hope

hotspot

focus

hotspot

entertainment